Biomarkers

Learn about mesothelioma biomarkers and how new research may start detecting this disease a lot sooner than expected. Read more.

Asia | Biomarkers | Diagnosis | International | New Studies | Prognosis | Research

Predicting Mesothelioma Outcomes with Soluble Mesothelin
ByAlex Strauss May 19, 2017

New research suggests that a protein often used to help diagnose and track malignant mesothelioma may also be a valuable…

Read More Predicting Mesothelioma Outcomes with Soluble Mesothelin
Asia | Biomarkers | Diagnosis | International | Prognosis

More Evidence for Inflammation Marker in Mesothelioma Prognosis
ByAlex Strauss April 24, 2017July 24, 2017

There is more evidence that a measure of how well the immune system is functioning may be an efficient prognostic…

Read More More Evidence for Inflammation Marker in Mesothelioma Prognosis
Biomarkers | Diagnosis | Europe | International | New Studies | Prognosis | Research | Updates

Diagnosing Pleural Mesothelioma with Lung Fluid: The Battle of the Biomarkers
ByAlex Strauss March 21, 2017April 12, 2017

A biomarker called soluble mesothelin related peptide (SMRP) may be a more reliable way to diagnose malignant pleural mesothelioma from…

Read More Diagnosing Pleural Mesothelioma with Lung Fluid: The Battle of the Biomarkers
Biomarkers | Diagnosis | Europe | Genetics | International | Prognosis | Research | Updates

BAP1 May Be Valuable for Peritoneal Mesothelioma Prognosis
ByAlex Strauss January 13, 2017March 16, 2017

There is new evidence that the same genetic mutation that is common in people with pleural mesothelioma may be present…

Read More BAP1 May Be Valuable for Peritoneal Mesothelioma Prognosis
Asia | Biomarkers | Diagnosis | International | New Studies | Prognosis | Research | Updates

Blood Test Could Aid in Mesothelioma Treatment Planning
ByAlex Strauss December 30, 2016March 16, 2017

Mesothelioma patients with elevated levels of a particular enzyme in their blood prior to the start of mesothelioma treatment may…

Read More Blood Test Could Aid in Mesothelioma Treatment Planning
Biomarkers | Canada | Diagnosis | Genetics | International | Prognosis | Research | Updates

Gene Test May Help Distinguish Pleural Mesothelioma from Lung Cancer
ByAlex Strauss December 21, 2016March 16, 2017

There is more evidence this week that the tumor suppressor gene known as BRCA1-associated protein 1 (BAP1) could help doctors…

Read More Gene Test May Help Distinguish Pleural Mesothelioma from Lung Cancer
Australia | Biomarkers | Canada | Diagnosis | International | Mesothelioma | Prognosis | Updates

International Team Identifies Potential New Mesothelioma Biomarker
ByAlex Strauss December 6, 2016March 16, 2017

A team of international researchers say they have identified a promising new biomarker for malignant pleural mesothelioma, a rare but…

Read More International Team Identifies Potential New Mesothelioma Biomarker
Biomarkers | Diagnosis | Europe | International | New Techniques | Prognosis | Updates

New Clinical Trial Aims to Create Bioresource for Improved Mesothelioma Diagnosis
ByAlex Strauss November 26, 2016March 16, 2017

Malignant mesothelioma is not only one of the rarest and most difficult-to-treat cancers. It is also among the hardest to…

Read More New Clinical Trial Aims to Create Bioresource for Improved Mesothelioma Diagnosis
Biomarkers | Diagnosis | Europe | International | New Studies | Prognosis | Research | Updates

Measuring Mesothelioma Treatment Response with Biomarkers
ByAlex Strauss November 10, 2016March 16, 2017

Malignant pleural mesothelioma is notoriously difficult to treat and doctors often have to try different treatment combinations to produce a…

Read More Measuring Mesothelioma Treatment Response with Biomarkers
Biomarkers | Diagnosis | Europe | International | New Studies | Prognosis | Research | Updates

New Marker for Mesothelioma Diagnosis and Follow-up
ByAlex Strauss October 24, 2016June 23, 2017

A protein most often used to measure the risk level in pregnancy may also offer a more reliable way to…

Read More New Marker for Mesothelioma Diagnosis and Follow-up

1 (888) 378-1331

Biomarkers

Predicting Mesothelioma Outcomes with Soluble Mesothelin

More Evidence for Inflammation Marker in Mesothelioma Prognosis

Diagnosing Pleural Mesothelioma with Lung Fluid: The Battle of the Biomarkers

BAP1 May Be Valuable for Peritoneal Mesothelioma Prognosis

Blood Test Could Aid in Mesothelioma Treatment Planning

Gene Test May Help Distinguish Pleural Mesothelioma from Lung Cancer

International Team Identifies Potential New Mesothelioma Biomarker

New Clinical Trial Aims to Create Bioresource for Improved Mesothelioma Diagnosis

Measuring Mesothelioma Treatment Response with Biomarkers

New Marker for Mesothelioma Diagnosis and Follow-up

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES